cp wire

CP Wire Articles

ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
  • Interim futility analysis supports trial coninuation
  • Mirvetuximab soravtansine is the first FRa-targeting ADC


ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the... read more

Thu, 04/26/18 - 07:56 pm
NoviDigm Therapeutics Publishes Positive Results for Candida Vaccine
  • 9 million women in the US report recurrent yeast infections
  • single dose led to reduced recurrences of vulvovaginal candidiasis
  • will also study against Staphylococcus aureus... read more
Thu, 04/26/18 - 01:44 pm
Innovent Biologics Takes in $150 million in Series E Round - May Drop U.S. IPO Plans

Innovent Biologics, Inc., announced the completion of its US$150 million Series E round financing.  

This round of financing attracted high quality global institutional investors and... read more

Thu, 04/26/18 - 10:16 am
Early Observations From Aduro Biotech's pLADD Immunotherapy Look Promising
  • pLADD induced neoantigen-specific CD8+ T cells undetectable before pLADD treatment started
  • pLADD induced an innate response exemplified by gamma delta T cells, also thought to be... read more
Thu, 04/26/18 - 09:55 am
CANbridge Receives China FDA Approval for Oral Mucositis Therapy

CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it received an Import Medical Device Market Approval from... read more

Thu, 04/26/18 - 09:12 am

Pages